.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
This clinical review examined the role of therapeutic bronchoscopy for malignant central airway obstruction, focusing on patient-centered outcomes as well as procedural risk. Central airway obstruction can cause severe dyspnoea, cough, recurrent infection, and impaired quality of life, sometimes creating an urgent need for symptom relief even when definitive cancer therapy is still being planned. The review emphasizes that bronchoscopic intervention can produce meaningful palliation and can be integrated with other oncologic treatments when appropriately selected. At the same time, these procedures carry risks, and the benefit–risk balance depends on anatomy, tumor burden, performance status, and local expertise. The paper is valuable for HCPs because it frames intervention as part of a multidisciplinary decision rather than simply a technical procedure. The conference’s emphasis on early referral for airway intervention and on building an MDT habit is well aligned with this approach. In practical terms, the right question is often not “Can this lesion be treated bronchoscopically?” but “Will timely airway intervention improve symptoms, safety, or the patient’s ability to receive the next stage of treatment?”
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This clinical review examined the role of therapeutic bronchoscopy for malignant central airway obstruction, focusing on patient-centered outcomes as well as procedural risk. Central airway obstruction can cause severe dyspnoea, cough, recurrent infection, and impaired quality of life, sometimes creating an urgent need for symptom relief even when definitive cancer therapy is still being planned. The review emphasizes that bronchoscopic intervention can produce meaningful palliation and can be integrated with other oncologic treatments when appropriately selected. At the same time, these procedures carry risks, and the benefit–risk balance depends on anatomy, tumor burden, performance status, and local expertise. The paper is valuable for HCPs because it frames intervention as part of a multidisciplinary decision rather than simply a technical procedure. The conference’s emphasis on early referral for airway intervention and on building an MDT habit is well aligned with this approach. In practical terms, the right question is often not “Can this lesion be treated bronchoscopically?” but “Will timely airway intervention improve symptoms, safety, or the patient’s ability to receive the next stage of treatment?”
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
